MDS Presidential Perspective: A New Approach to the Development of Disease-Modifying Therapies for Parkinson's Disease; Fighting Another Pandemic - presented by: Dr. Warren Olanow

Introduction

MDS Presidential Perspective: A New Approach to the Development of Disease-Modifying Therapies for Parkinson's Disease; Fighting Another Pandemic - presented by: Dr. Warren Olanow

Course Format

Webinar

Release Date

February 03, 2021

Expiration Date

December 31, 2022

Program Description

The MDS Presidential Perspective: A New Approach to the Development of Disease-Modifying Therapies for Parkinson's Disease; Fighting Another Pandemic course focuses on discussing development of a disease modifying therapy as it is a major unmet therapeutic need in Parkinson's disease. Despite the many promising targets and candidate therapies, many pharmaceutical companies are abandoning this field because of the development costs and regulatory uncertainties. The lecture describes a new approach that Dr. Olanow believes can overcome these problems.

Course has been expired

Faculty

C. Warren Olanow MD, FRCPC, FRCP - Clintrex Research Corp, Mount Sinai School of Medicine, New York City, New York, USA

Course Purpose

The primary purpose of this webinar is to provide information on a new approach to the development of disease-modifying therapies for Parkinson's disease

Learning Objectives

Upon completion of this activity learners will be able to:

1. Be familiar with obstacles to development of a putative disease modifying therapy for Parkinson's disease

2. Know the clinical designs that have been used to date to try and define a disease modifying therapy

3.Appreciate a new approach to developing disease modifying therapies for Parkinson's disease

Intended Audience

This activity is intended for movement disorder specialists, neurologists, and individuals in the biotech and pharmaceutical industry who are potentially interested in developing disease modifying therapies for Parkinson's disease

Method of Participation

The course must be attended in their entirety. Partial credit is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.

Staff Disclosure

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.